13. Aug 2026
Description
(AWP Alliance News) - PolyPeptide Group AG reported H1 2026 revenue of EUR 236.63 million, up 41.6% from H1 2025, while EBITDA more than doubled to EUR 49.09 million from EUR 4.43 million. EBITDA margin widened to 20.7% from 2.7%, while operating result swung to EBIT of EUR 21.98 million from an operating loss.
The group returned to profit with net income of EUR 9.08 million and EPS of EUR 0.28, versus a net loss a year earlier. Net cash flow from operating activities fell 49.2% to EUR 25.22 million, while capital expenditures declined 10.4% to EUR 41.32 million.
PolyPeptide raised its 2026 outlook to 25-30% revenue growth and said it now expects an EBITDA margin in the high-teens.
https://www.publicnow.com/view/196BB2E4CF390433D9BFF12BBB7288AD933FFD4D…
Disclaimer: This news brief was created using generative artificial intelligence. PolyPeptide Group AG published the original content used to generate this news brief via EQS News on August 13, 2026, and is solely responsible for the information contained therein.
